Prostate Carcinoma Metastatic to the Bone
4 clinical trials · Condition
◉ Watch Prostate Carcinoma Metastatic to the Bone
| Record | Firm | Date |
|---|---|---|
| Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) (NCT03076203) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-09-22 |
| A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) (NCT02384382) | Pfizer | 2015-11-30 |
| Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis (NCT02507570) | Carolina Research Professionals, LLC | 2015-09-23 |
| Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer (NCT02458716) | Rutgers, The State University of New Jersey | 2015-03-06 |
Track Prostate Carcinoma Metastatic to the Bone automatically
Every clearance here is in the API, with alerts when new ones post.